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INTRODUCTION

The kidney has one of the most diverse cellular populations and
spatial organization in the human body, and it is critical in maintaining the physiological homeostasis by regulating fluid and
electrolyte balance, osmolarity, and pH. The basic unit of organization in the kidney is the nephron embedded in the interstitium; the
human kidney has between 210,000 and 2.7 million nephrons.
There are multiple cell types in the nephron and the interstitium
including those that comprise the blood vessels and capillaries
(such as endothelial cells and vascular smooth muscle cells) and
many types of immune cells.
For decades, there has been a sustained effort to develop a detailed
understanding of structure-function-endophenotype relationships
within the kidney tissue to understand its physiology and pathophysiology (1). Over the past decade, with the advent of single-cell (sc)
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RNA sequencing (RNAseq) technologies, substantial advances have
been made in enumerating the different cell types in the human
and mouse kidney (2–11). Computational analyses and modeling
of sc transcriptomic data and other omics data are starting to provide rich and deep insight into different kidney disease processes,
including kidney cancers (11) and fibrosis (6). These studies
demonstrate the power of omics technologies in developing atlases
that map structure-function relationships at the single-cell level
within tissues.
Datasets from different omics technologies provide an unparalleled opportunity to understand how the diversity of cell types
and their constituents underlie physiological functions and how
they are altered in different disease states. The Kidney Precision
Medicine Project (KPMP) is a consortium funded by the National
Institute of Diabetes and Digestive and Kidney Diseases. Using
kidney biopsies that are ethically and safely obtained from participants with kidney disease, KPMP aims to create a kidney atlas in
health and disease. Such an atlas can identify critical cells, pathways,
and targets for novel therapies and preventive strategies (12, 13). To
identify and understand disease states, it is necessary to have a
detailed atlas of tissues that do not show disease phenotype by
standard clinical histopathological evaluation. We call such an atlas
“a reference atlas.” Using multiple reference kidney sources, different
groups in the consortium have generated diverse types of data.
Among these are single-nucleus (sn) (14) and sc (15) transcriptomics, regional bulk transcriptomics, proteomics, and metabolomics, as
well as multiple complementary types of imaging methods. We
have analyzed and integrated these different data types obtained
from reference kidney tissue specimens, as evaluated by standard
pathology analysis, from 56 adult human subjects and analyzed
80,289 single cells. For quality control, we also assessed 24,282 additional
1 of 20
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Kidney Precision Medicine Project (KPMP) is building a spatially specified human kidney tissue atlas in health and
disease with single-cell resolution. Here, we describe the construction of an integrated reference map of cells,
pathways, and genes using unaffected regions of nephrectomy tissues and undiseased human biopsies from
56 adult subjects. We use single-cell/nucleus transcriptomics, subsegmental laser microdissection transcriptomics
and proteomics, near-single-cell proteomics, 3D and CODEX imaging, and spatial metabolomics to hierarchically
identify genes, pathways, and cells. Integrated data from these different technologies coherently identify cell
types/subtypes within different nephron segments and the interstitium. These profiles describe cell-level functional organization of the kidney following its physiological functions and link cell subtypes to genes, proteins,
metabolites, and pathways. They further show that messenger RNA levels along the nephron are congruent with
the subsegmental physiological activity. This reference atlas provides a framework for the classification of kidney
disease when multiple molecular mechanisms underlie convergent clinical phenotypes.
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single cells from public sn RNAseq data from the literature (16, 17).
We constructed maps of the different cell types in the kidney and
the molecular entities and functional pathways within these cell
types to develop the first version of a reference human kidney atlas.
To determine whether the molecular details in the atlas enable previously unknown insights into physiological activity, we compare
our data to the transcellular sodium reabsorption along the
nephron, which is essential for maintaining normal blood pressure
in individuals with normo- and hypertension (18). We find strong
congruence between physiological activity and the mRNA expression
signatures of different sodium transporters, indicating that such a
detailed atlas can provide a deeper understanding of the molecular
and cellular principles underlying physiological processes. All data
presented in this study are available for download, and as an interactive cellular atlas (atlas.kpmp.org/explorer) to serve as a starting
point from which data of disease states can be projected onto a
functional context to drive new molecular classification of kidney
disease.

The KPMP Consortium conducted different types of omics assays
and low-throughput imaging experiments at different sites for these
reference atlas studies. Although it is impossible to definitively
characterize tissue as healthy, clinical pathologists adjudicated that
the specimens used in this study show no structural signs of disease
manifestations. Nevertheless, since we use unaffected tissue regions
from nephrectomies and biopsies from both living donors and
transplant recipients (i.e., surveillance biopsies), we use the general
term reference tissue (table S1). In future studies, these can be compared to diseased tissue specimens.
There were four transcriptomic, two proteomic, two imaging-based,
and one spatial metabolomics tissue interrogation assays deployed
on the shared tissue samples (Fig. 1A). These assays yielded 3 to
48 different datasets obtained from 3 to 22 subjects per assay for a
total of 56 different adult human subjects (table S1). The assays and
their detailed tissue preanalytical, tissue processing, data acquisition,
and analytical data processing pipelines are schematically depicted
as a flowchart in Fig. 1B. We also summarize, in the integration
segment of our flowchart, the steps by which the datasets from
different assays were integrated and harmonized. This is shown on
the upper right side of the descriptive map.
Integration of multiple transcriptomic interrogation
techniques shows agreement and technological synergy
between assays
Separate and integrated analysis of sc, multiplexed sc, and sn transcriptomic datasets confirmed all known major kidney tissue
cell types of the nephron and multiple immune cells (Fig. 2A).
Clustering algorithms used to analyze the sc and sn RNAseq data
separately identified multiple subtypes for several cells. We observed
differences between the numbers of subtypes in the sc versus sn data
as different cutoffs were used in the initial analyses (14, 15). Nevertheless, when sc and sn RNAseq data were analyzed in an integrated
manner, all major cell types were identified, as shown in the central
panel in Fig. 2A, yielding 16 main clusters (note that some clusters
contain multiple closely related subtypes). These clusters were
annotated to 14 cell types based on cluster-specific marker gene
expression (fig. S1G). Almost every cluster contained cells and nuclei
Hansen et al., Sci. Adv. 8, eabn4965 (2022)
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Proteomic and transcriptomic assays produce
biologically complementary descriptions of
subsegmental molecular composition
In addition to transcriptomic profiles, we present subsegment-
specific protein expression profiles using two different proteomic
assays. These assays identify protein expression in the glomerulus
and the tubulointerstitium (LMD proteomics) or PT [near-single-cell
(NSC) proteomics] (tables S3 and S4, respectively). For an unbiased
cross-platform comparison, we focused on podocyte/glomerular
and PT cells and subsegments in the four transcriptomic datasets.
Pairwise correlation of logarithmic ratios of gene or protein expression
values for the glomerular versus tubular cell types or subsegments
(fig. S2A) followed by hierarchical clustering resulted in grouping
of the datasets by appropriate regions of the kidney (Fig. 2C; see fig.
S2B for quantitative information about the clustering heights in the
dendrogram). Within this broad classification, the subgroupings by
different assays could be readily identified and are shown (right-side
labels in Fig. 2C). From this clustering, we conclude that irrespective of the assay, we can readily identify groups of genes or proteins
associated with the appropriate anatomical region (i.e., glomerulus
versus tubulointerstitium). This pattern is observed with or without
the removal of genes or proteins that are not identified by all technologies (fig. S2C). In contrast, if we cluster by absolute expression
values, the clustering is primarily driven by the assay used rather
than the anatomical region. This is irrespective of whether we use
datasets with and without removing genes or proteins not detected
by all technologies (fig. S2, D and E, respectively). These results
suggest that rather than the absolute presence or absence of the
different genes or proteins, the relative expression levels are more
indicative of the corresponding anatomical region of the kidney.
Correlation analysis of averaged log2 fold changes between all
combined RNAseq and proteomic datasets suggests that similar
entities are identified by different assays (Fig. 2D). The 0.61 correlation value that we obtain agrees with the canonical value across
mammalian tissues as described in (20). However, our comparison
is based on fold changes and not absolute mRNA and protein abundances. Hence, integration of multiple datasets increases the accuracy of the results since integrated RNAseq and proteomic datasets
show a higher correlation than any individual RNAseq and proteomic
datasets. Nevertheless, correlation coefficients are high between
technologies where assays were conducted at different sites (Fig. 2E).
2 of 20
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RESULTS

from every dataset, documenting consistency of our transcriptomic
datasets (fig. S1E). For quality control measures see fig. S1 (A to G).
To provide spatial context with respect to different regions of the
nephron, we compared the sc and sn transcriptomic datasets with
nephron segment–specific bulk transcriptomic datasets that were
obtained after laser microdissection (LMD) of kidney segments
(table S2) (19). Cross-assay Pearson correlation analysis shows that
there is strong concordance across the data obtained by the different technologies, whereby most of the cells and nuclei from each
cluster were assigned to the correct corresponding LMD subsegment
in an unbiased manner (Fig. 2B). For example, 83% proximal tubule
(PT) cells were assigned to the PT subsegment, while 99.5% podocytes were assigned to the glomerular subsegment. As the total
numbers of cells analyzed are modest compared to some of the
recent reports, we evaluated whether other independent technologies
improve the overall atlas framework using integration of orthogonal
omics assays and post hoc power analyses.
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Fig. 1. Graphic outline of KPMP data integration and harmonization procedures. The “subway map” representation of the experimental and analytical protocols used
within KPMP is shown in operational flow from kidney biopsy to the integrated multimodal data represented in this manuscript. The kidney biopsy, which is processed
through three different tissue processing methods, is shared among tissue interrogation sites (TISs) that generate the data. Four key modalities of molecular data are
generated: transcriptomic (red), proteomic (blue), imaging (yellow), and metabolomic (green). Biopsy cores 2 and 3 are used for the molecular analysis; biopsy core 1
(not depicted) is used for histological analysis.
Hansen et al., Sci. Adv. 8, eabn4965 (2022)
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Fig. 2. Integration of transcriptomic, proteomic, and image-based assays documents concordance across different omics technologies. (A) Scheme showing the
major nephron segments as identified in our datasets. Sc and sn datasets were either analyzed separately or combined. Uniform manifold approximation and projection
documents the results of the combined analysis. Cell subtype counts were obtained from the separated analyses (fig. S4, A and B). The corresponding LMD segments
shown include the markers used to identify each subsegment: phalloidin, fluorescein isothiocyanate–labeled phalloidin for dissection of glomeruli and other structures;
LRP2, megalin with Alexa Fluor 568 secondary (red); UMOD, directly conjugated Alexa Fluor 546 antibody to uromodulin (red); fluorescein-labeled PNA, peanut agglutinin
labels collecting ducts (green); 4′,6-Diamidino-2-phenylindole was included for nuclei (blue). (B) We used Pearson correlation analysis of gene expression data to identify
the closed subsegment in the LMD RNAseq data for each cell or nucleus in the combined transcriptomic analysis. Numbers document the number of cells/nuclei of each
cluster mapped to each segment. (C) We calculated log2 fold changes between podocyte (or glomerulus) and PT cells (or tubulointerstitium) for each subject based on
each assay. Pairwise correlation coefficients between all log2 fold changes were determined and used for hierarchical clustering. The variation in the axial ranges
represents the divergences in the dynamic range of different assays as the axes are non-normalized. (D) Log2 fold changes obtained by the same assay were averaged
across all subjects, followed by averaging of the results across all four transcriptomics and two proteomics assays. Positive or negative log2 fold changes indicate podocyte/
glomerular or PT/tubulointerstitial expression. (E) Pairwise correlations between the sc/sn RNAseq and proteomic datasets document highest concordance between both
proteomic and single-cell assays. Positive and negative log2 fold changes indicate podocyte/glomerular and PT/tubulointerstitial expression, respectively.
Hansen et al., Sci. Adv. 8, eabn4965 (2022)
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Imaging-based molecular data and nonspatial proteomic
and transcriptomic assays together produce spatial marker
expression signatures
Imaging assays can provide the spatial specification of omics data,
such as bulk proteomics (21), and help characterize the contextual
framework for cell types inferred through dissociated cell transcriptomics; those with well-characterized markers can identify the
spatial localization of individual cells, which can be independently
identified from gene expression patterns. By analyzing the relationship between cells identified from sc/sn sequencing technologies
and co-detection by indexing (CODEX) imaging of canonical
markers across 27,236 cells, we establish the concordance between
the assay types for independently identifying cell types and inferring
molecular profiles for spatially localized cells (Fig. 3). We find a
strong correspondence between the molecular profiles of cell types
across data modalities (Fig. 3 and fig. S3). By mapping sc/sn expression profiles to either LMD segments or the independent imaging
assays, we were able to further assign dissociated transcriptomic
signatures to anatomical regions within the kidney. Using these comparisons, we can arrange different cell subtypes along the nephron

and in the interstitium, allowing documentation of the order by which
they encounter the glomerular ultrafiltrate in the reference state.
Integrated pathway enrichment analysis enables
identification of functional capabilities of different cell types
of the kidney
After establishing the consistency between transcriptomic, proteomic,
and imaging datasets, we used these integrated data to identify the
cell type–specific functional pathways and network modules. We
started by individual analyses of the sc/sn RNAseq datasets and by
identifying the pathways inferred from the expressed genes (14, 15).
Individualized analyses of sc/sn transcriptomic data ensure that
these two related technologies do not computationally influence
each other. In contrast to our integrated analysis of these datasets
described above, the individual analyses used more relaxed quality
control cutoffs, such as allowing up to 50% mitochondrial gene
expression, so the cell subtype–specific gene expression obtained by the
sc RNAseq dataset was based on 22,264 cells instead of 17,529 cells
after quality control. The number of nuclei after quality control was
the same with 17,659 nuclei. These dissociated cell analyses also
Downloaded from https://www.science.org at Washington University on August 29, 2022

Fig. 3. Integration of single-cell and nucleus transcriptomic data with CODEX imaging data. (A) CODEX imaging provides spatial localization for 30 proteins across
27,236 cells (spatial distribution of selected proteins visualized). (B) CODEX data were clustered using X-shift clustering to identify groups of cells expressing common
subsets of protein markers. (C) Each CODEX cluster was mapped to the most similar transcriptomic cluster based on the Pearson correlation between the average scaled
expression profiles. (D) Visualization of CODEX clusters in spatial context. Yellow dots indicate cells mapped to each cluster, and the side-by-side average expression
profiles of the CODEX cluster and corresponding mapped transcriptomic cluster are shown.
Hansen et al., Sci. Adv. 8, eabn4965 (2022)
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allowed us to ascertain that all cell types could be observed independently of the method by which the reference tissue was obtained.
We find that all major kidney cell types can be identified in
nephrectomy, living donor biopsy, and transplant surveillance
biopsy tissues based on the individual sc and sn RNAseq datasets
(fig. S4, A and B, respectively). An exception to this finding is that
immune cells were mostly identified only within the sc RNAseq
dataset, while only one cluster of the sn RNAseq dataset that contained less than 1% of all nuclei was annotated to an immune cell
type, i.e., macrophage (fig. S4B). Almost all cells identified in sc or
sn RNAseq datasets in the individualized analyses were annotated
to the same cell type as in the combined analysis (fig. S4, C and D,
respectively), expressed cell type–specific marker genes (fig. S4, E
and F, respectively), and mapped to the appropriate LMD segment
as well (fig. S4, G and H, respectively).

Hansen et al., Sci. Adv. 8, eabn4965 (2022)
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Comparison of variation of oxygen supply and inferred
levels of energy metabolism help identify sites vulnerable
for kidney injury
To identify energy generation pathways in the different cells along
the renal tubule of the nephron, we generated a focused ontology of
metabolic pathways (fig. S18A). Using this ontology for enrichment
analysis allowed us to distinguish between aerobic and anaerobic as well
as catabolic and anabolic pathways (fig. S18B). To rigorously define the
groups, we used a rule-based analysis that ignores predicted parent
pathways if a given child that contains the reactions specific for the
6 of 20
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Post hoc power analysis documents consistent cell type
detection and affirms adequate sampling
Before focusing on cell type–specific functions that we predicted
from pathway enrichment analysis and module mappings, we
evaluated how many reference subject samples need to be processed to
obtain consistently reproducible results. Twenty-four and 47 libraries
obtained from 22 and 15 subjects were subjected to sc (15) and sn
(14) RNAseq (table S1), yielding 22,264 cells and 17,655 nuclei after
quality control, respectively. We separately subjected both RNAseq
datasets to a standardized sc and sn RNAseq analysis pipeline with
and without random and progressive removal of libraries (fig. S5A).
Our analysis pipeline automatically screens for an optimal clustering
resolution to identify as many major kidney cells with high confidence as possible. Results obtained for the downsampled datasets
were compared to those obtained for the complete datasets (fig.
S5B). Our results indicate that for a consistent detection of podocytes (i.e., in at least 95% of all downsampled datasets with the same
library counts), at least seven (6403 cells) or five libraries (1921 nuclei)
are needed if subjected to sc RNAseq (Fig. 4A) or sn RNAseq
(Fig. 4B), respectively. The observed higher identification rate by
the sn RNAseq assay agrees with a previous report that compared sn
and sc RNAseq results obtained from mouse kidneys (10). PT cells,
thick ascending limb (TAL) cells, principal cells (PC), intercalated
cells (IC), and T cells were always detected in the downsampled
sc RNAseq datasets. Macrophages (MAC), glomerular endothelial
cells (GO-EC), and two other endothelial cell (EC) types were
consistently detected if three (2843 cells), three, or four libraries
(3817 cells), respectively, were analyzed. In the sn RNAseq datasets,
we consistently detected PT cells, TAL cells, distal convoluted tubule
cells (DTL), connecting tubule (CNT) cells, principal cells, and
intercalated cells in 3, 6, 9, 13, 6, and 4 libraries (1043, 2235, 3395,
4930, 2235, and 1464 nuclei), respectively. Descending limb cells were
first detected in 95% of all downsampled datasets at a library count
of five (1921 nuclei). For additional cell types, see Fig. 4 (A and B). In
addition, our results suggest that the accuracy of sc or sn assignments to the selected cell types is relatively stable, as documented by
the low number of cells that are assigned as different cell types or mapped
to an unrelated tissue subsegment in the downsampled sc and sn
datasets (fig. S5, C and D, respectively). Similarly, Pearson correlation
between cell type–specific differentially expressed genes (DEGs) in
the downsampled and complete datasets follow the same trend. These
analyses establish the rigor with which we are able to assign pathways and physiological functions to the different cell types.

Pathway enrichment analysis and module identification
helps understand molecular basis of physiological functions
with cellular resolution
The top 300 significant gene and protein markers of each cell type
or subtype and subsegment (table S5) were subjected to dynamic
enrichment analysis using the Molecular Biology of the Cell Ontology
(MBCO; table S7) (22). In many cases, less than 300 markers were
significant (table S6), and we consequently used only those for our
downstream analysis. In contrast to standard enrichment analysis,
dynamic enrichment analysis is not limited to a single process but
instead determines whether a set of experimental genes maps to
multiple functionally related subcellular processes (SCPs). Resulting
SCP networks can give rise to whole-cell physiological function.
Nonglomerular and glomerular metabolites (table S8) were subjected
to pathway enrichment analysis using MetaboAnalyst (fig. S6, A
and B, respectively) (23) and predicted pathways mapped to MBCO
SCPs. Similarly, we subjected significant mRNA and protein markers
to community clustering in a kidney-specific functional network
using HumanBase (table S9) (24, 25), which was constructed by
integrating thousands of public genomic datasets using a regularized
Bayesian framework to predict the probability that every pair of
genes in the genome is related in a specific tissue context. Combining both network approaches, we created a detailed map of pathway
activities in all major cell types in the kidney, which is described
and discussed in detail within the “Cells of the kidney” section in
Supplementary Information. As documented by the high metabolic,
reabsorption and detoxification activity predicted for the PT cells
(Fig. 5, A and B), our approach identified many well-known cellular
activities for most kidney cell types and numerous previously unknown functions (figs. S7 and S16).
Using a similar approach to our post hoc power analysis, we
investigated the robustness of the SCP-identified cell biological
functions by randomly downsampling libraries from the sc/sn datasets. Investigation of the ranks that were obtained for downsampled
SCPs allows estimation of SCPs that are consistently predicted and
are probably describing core biological functions. In case of the PT
cells, most of the consistently identified SCPs by the sc (fig. S17A)
or sn RNAseq data (fig. S17H) are related to cellular metabolism
and energy generation, reabsorption, and detoxification. In the case
of the podocytes, the consistently identified SCPs are involved in
cell-cell and cell-matrix adhesion. Among other cell adhesion
pathways, we consistently identify the two SCPs “tight junction
organization” and “adherens junction organization” based on both
the sc (fig. S17B) and sn RNAseq assay (fig. S17I). These results
document the central importance of the glomerular slit diaphragm
that is described as a specialized form of both tight junctions (26)
and adherens junctions (27). Figure S17 also shows the results
obtained for the other cell types.
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Fig. 4. Single-cell/nucleus transcriptomic post hoc power analyses show that nine libraries are sufficient to identify most major kidney cell types. Subject libraries
(or samples) were randomly and progressively removed from (A) the sc (24 libraries) and (B) sn (47 libraries) RNAseq to generate at maximum 100 non-overlapping random
groups for the remaining samples. Sc and sn datasets were subjected to an automated data analysis pipeline (fig. S5A). To assign cell types to the identified clusters, we
compared cluster-specific markers of each analysis with literature curated cell type–specific genes (fig. S5B). We counted how many analyses based on the same number
of remaining libraries that have identified a particular cell type. Horizontal dashed lines mark the 95% plateau; vertical dashed lines indicate the lowest library quantity
that allowed identification of a given cell type with a probability of 95%. See fig. S5 for complete post hoc power analysis results. See Fig. 2A for cell type abbreviations.

parent pathway was not among the predictions. For example, the
pathway anaerobic glycolysis was only considered if the pathway
lactate dehydrogenase was predicted as well. See Methods for details.
Expression patterns of different pathways involved in aerobic
and anaerobic energy generation (Fig. 6 and table S11) were mapped
Hansen et al., Sci. Adv. 8, eabn4965 (2022)
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to the varying levels of oxygen availability in different regions of
the nephron (28). This comparison helped us identify regions with
high susceptibility toward hypoxia-induced kidney injury. Missing
capability for anaerobic energy generation as predicted from the
human transcriptomics data (Fig. 6 and fig. S18B) and observed in
7 of 20
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Fig. 5. Enrichment analysis of markers for PT and glomerular cells and segments predicts well-known cell functions. (A) Marker genes and proteins of each PT cell
subtype or subsegment were subjected to dynamic enrichment analysis using the MBCO. SCPs that were among the top seven predictions were connected by dashed
lines, if their interaction was part of the top 25% inferred MBCO SCP interactions, and by dotted lines, if their functional relationship was curated from the literature. Figure
S8 shows additional predicted SCPs involved in cell adhesion and translation. Metabolites associated with nonglomerular compartments were subjected to MetaboAnalyst
enrichment analysis (fig. S6). Any pathway among the top eight predicted pathways that was predicted on the basis of metabolites specifically for that pathway was
mapped to MBCO SCPs, if possible, and integrated into the PT SCP network. MBCO SCPs carnitine shuttle and carnitine biosynthesis and transport were added to the
predicted MetaboAnalyst pathways since four and two involved metabolites were among the nonglomerular metabolites (see Methods for details). (B) HumanBase
analysis of PT marker genes and proteins.

animal experiments (29) combined with already low pO2 in the
healthy kidney suggests S3 segment of the PT as a primary site for
hypoxia-based injury. This reasoning agrees with experimental
observations (28). High levels of capacity for aerobic energy generation activity in the medullary TAL (mTAL), a region with low
oxygen supply, are complemented by high capacity for anaerobic
Hansen et al., Sci. Adv. 8, eabn4965 (2022)

8 June 2022

energy generation, as also documented in animal experiments (29).
When the output of the anaerobic energy generation is depleted,
mTAL can become a second site of kidney injury. Our conclusion
agrees with the experimental observation that mTAL injury during
hypoxia depends on epithelial transport activity (28). It can be readily seen that molecular profiles of metabolic pathways in our atlas
8 of 20
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Fig. 6. Aerobic and anaerobic energy generation profiles and oxygen supply
accurately highlights sites of hypoxia-induced injury. To compare energy
generation profiles with experimentally determined oxygen supply in the different
nephron regions, we generated an ontology that allows the separation of aerobic
and anaerobic pathways involved in energy generation. Enrichment analysis of cell
type, subtype, and subsegment marker genes with this ontology predicts high
dependency of PT cells on aerobic energy generation, suggesting S3 as a primary
injury site during hypoxia (marked by two explosions) because of its low oxygen
supply under basal conditions. Enrichment results predict a high aerobic energy
generation activity for the mTAL that can be compensated by anaerobic energy
generation. In combination with the already low oxygen saturation in that segment
under normal conditions, our results suggest that mTAL is the second, although
less likely, injury site during hypoxia (marked by one explosion). Enrichment results
are combined from those shown in fig. S18B. Numbers in boxes indicate pO2 in mmHg
taken from (28). NA, not available.

provide a basis for understanding and predicting kidney injury due
to hypoxia in the clinical setting.
Predicted reabsorption capacities agree with experimental
reabsorption profiles and provide a molecular basis
for differential physiological activity along the nephron
Physiological experiments allow us to determine what percentage of a
filtered ion or small molecule is reabsorbed in a particular nephron
segment or excreted into the kidney pelvis and ureter. Sodium is the
central ion for all reabsorption activities; hence, we focused on
sodium reabsorption as an example of how a tissue atlas with cellular
resolution can help us understand physiological homeostasis. We
averaged sodium reabsorption profiles obtained from four different
standard physiology and school textbooks (30–33) (Fig. 7A). Since
we estimated that 37% (34) and 30% (35) of the total sodium in the
PT and loop of Henle are respectively reabsorbed by passive paracellular mechanisms, we removed those percentages from the
reabsorption profiles. Modified experimental values were renormalized
(Fig. 7A), and an ontology for sodium transport mechanisms across
the plasma membrane was generated (fig. S19, A to C) to predict
sodium reabsorption capacities from transcriptomic data. Using our
sn RNAseq dataset (14) and two additional sets from the literature
Hansen et al., Sci. Adv. 8, eabn4965 (2022)

8 June 2022

DISCUSSION

The integration of multiple types of omics data allows us to describe
in depth multiple SCPs and pathways at cell-level resolution. High
cross-correlation coefficients for independent technology pairs and
the successful unbiased clustering of segments affirm the high
quality of our data, as technological bias can be overcome by a relatively simple algorithm. From such an integrated description, we
can hypothesize key functions that can help define disease states
when perturbed. These disease states could have convergent clinical
phenotypes, although the underlying molecular changes are different.
Thus, our detailed characterization of the reference state described
here can provide a new framework for molecular classification of
9 of 20

Downloaded from https://www.science.org at Washington University on August 29, 2022

-Log10(P)

Mitochondrial beta-oxidation

(16, 17), we calculated the sum of all mRNA levels mapping to sodium
transporter genes across all cells in each segment. Averaged results
compared well with the experimentally measured reabsorption
profiles both without (fig. S19D) and with (Fig. 7B) the removal
of paracellular reabsorption. As the spare capacity for sodium reabsorption is most likely to be within the loop of Henle (36–39), our
data show substantial agreement between calculated capacities and
the experimentally measured reabsorption profiles.
Some nephron segments, such as the loop of Henle and the
collecting duct, contain multiple cell types with different reabsorption
mechanisms (36, 40); hence, we mostly focus on cell type–specific
transport mechanisms (Fig. 7C). We define mRNA levels mapping
to transporters involved in blood-to-lumen transport (table S12) as
negative to account for the opposite direction when compared to
lumen-to-blood transport. Adding all transporter mRNA levels of
each segment gives the net transport capacities described above
(Fig. 7B). Regarding individual transport mechanisms, we highlight
two details here (Fig. 7C): In the PT, we find high capacity for sodium-
coupled transport of multiple molecules, such as amino acids, organic anions, and sugars. In agreement, sodium reabsorption in the
PT is the driver for the absorption of many metabolites (30–33).
mRNA encoding NKCC2 is the predominant species of sodium
transporter in the TAL cells, in agreement with the large contribution
of NKCC2 to sodium reabsorption in the TAL (36). We acknowledge
that the epithelial Na channel ENaC (SCNN1) plays a major role in
sodium absorption in the connecting tubule and collecting duct,
where it reabsorbs ~5% of the filtered load of sodium (18), but our
analysis focuses only on transporters and excludes channels. This
probably explains our prediction of a higher blood-to-lumen versus
lumen-to-blood sodium transport in the collecting duct. Calculation of the reabsorption capacities after inclusion of our sc RNAseq
dataset along with sn RNAseq data slightly decreases the match
with the physiological reabsorption profiles and mRNA levels
(fig. S19E) but still gives similarly favorable results (fig. S19F). The
decrease is mainly due to the high mRNA levels associated with the
basolateral amino acid transporter LAT1 that exports cationic
amino acids into the blood in exchange for large neutral amino acids
and sodium (fig. S19F) (41).
In summary, the cell-level atlas provides a detailed picture of
sodium reabsorption that agrees with experimental reabsorption
profiles and was up to now not attainable. Similarly to sodium, we
find that glucose transport along the nephron agrees with glucose
transporter mRNAs (fig. S19, G and I) and is mainly mediated by
SGLT2 (fig. S19, H and J), the glucose symporter responsible for
over 80% of filtered glucose reabsorption in the PT (42).
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Fig. 7. Predicted sodium transport capacities match with experimentally determined reabsorption profiles. (A) Estimated transcellular sodium reabsorption
before and after removal of estimated paracellular sodium reabsorption from experimentally determined total sodium reabsorption profiles. (B) Using our and two
other sn RNAseq datasets, we calculated the sum of all mRNA counts that mapped to genes involved in sodium lumen-to-blood (L2B) and blood-to-lumen (B2L) transport
for each segment of the renal tubule. Net reabsorption capacities for sodium (colored bars) were determined by subtracting both sums and compared to experimentally
determined transcellular sodium reabsorption (gray bars). (C) L2B and B2L cell type–specific transport mechanisms for sodium are visualized above and below the abscissa,
respectively. Error bars document SEs. Parent-child relationships are documented in the legend, where children SCPs are written below their parent SCPs and shifted to
the right. To prevent double counting, we removed any mRNA levels from each parent SCP that are already visualized as part of its child SCPs. Parent SCPs missing in the
diagram were added to the legend next to an uncolored box for a proper documentation of the SCP hierarchy. In case of multiple parent SCPs, we only show one parent.
Stacked bar diagram colors are in the same or reverse order as in the legend for L2B and B2L, respectively.

kidney diseases. For example, identification of both mitochondrial
and peroxisomal -oxidation and carnitine transport and local
biosynthesis pathway in PT cells suggests how individual variations
in any of these SCPs can contribute to the effects of kidney injury,
including fibrosis (6). Thus, a convergent clinical phenotype can
arise from very different molecular changes related to energy
metabolism. Mapping these changes in individual patients may
allow for better classification of disease states.
Integrated view of kidney cellular functions
One advantage of the presented multiomics data integration strategy
is the ability to infer how different classes of biomolecules may enable
complex multicellular functions leading to potentially predictive
biomarkers. Spatial metabolomics identifies N-palmitoylsphingomyelin
(SM d18:1/16:0) as a spatial correlate of glomerular kidney segments
(correlation coefficient > 0.9; Fig. 8A), as described previously
Hansen et al., Sci. Adv. 8, eabn4965 (2022)
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(43, 44). To identify the cell types involved in its synthesis, we
screened all glomerular cell types for expression of genes involved
in ceramide, sphingomyelin, and sphingosine metabolism (45, 46).
Transcriptomics identify SERINC5 (serine incorporator 5) and
CERS6 (ceramide synthetase 6) as specifically expressed in podocytes or in podocytes and mesangial cells, respectively (Fig. 8B).
SERINC5 incorporates serine into the membrane of the endoplasmic
reticulum, making it available for ceramide and phosphatidylserine
synthesis (45). CERS6 is identified by all transcriptomic assays in
the podocyte. CERS6 is one of six ceramide synthases that converts
sphingosine and acyl–coenzyme A (acyl-CoA) into ceramide. In
contrast to the other five ceramide synthases, it has a high substrate
specificity toward palmitoyl-CoA (C16:0) (46), thereby generating
ceramides with the correct acyl chain length to be converted into
SM d18:1/16:0. Only one technology, sn RNAseq, shows CERS6 to
be expressed in mesangial cells as well, albeit at a lower level of
10 of 20
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significance (rank 293 in mesangial cells versus 116 and 126 in
podocytes; fig. S20).
Transcriptomic datasets also predict the expression of enzymes
involved in sphingomyelin synthesis in nonglomerular cells. In
general, only one specific enzyme of this pathway is expressed per
cell type. Consequently, podocytes (and mesangial cells) are the
most likely synthesis site(s) for this particular sphingomyelin, as
demonstrated by the spatial metabolomics data. Altered metabolism
of multiple sphingolipids including sphingomyelin and its metabolites is observed in several glomerular diseases (47). Cellular
sphingomyelin is predominantly localized at membranes derived
from the trans-Golgi and plasma membrane (48). It is involved
in multiple functions, including cell signaling, lipid rafts formation
(49), caveolar endocytosis (48), and apoptosis (50). In addition, it
has long been known that sphingomyelin (as part of lipid rafts) is
enriched in desmosomes (49, 51) and tight junctions (52). Given the
central importance of foot process interactions between neighboring
podocytes, the potential importance of this metabolite in making
different types of cell-cell contacts and the enzymes involved in its
biosynthesis in podocytes can be readily appreciated. Five technologies that focus on genes and proteins identify cell-cell/cell-matrix
adhesion as podocyte key functions, and the sixth technology identifies a specific metabolite that we consequently predict would be
involved in the same key functions, thus providing integrated
support for the role of sphingomyelins in podocyte cell-cell interactions. Sphingomyelin with very long (C24) acyl chains, but not
palmitoyl (C16) sphingomyelin, is the predominant species associated with tight junctions (52). Tight and adherens junctions are
morphologically only observed in developing or diseased podocytes
Hansen et al., Sci. Adv. 8, eabn4965 (2022)
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The value of a reference tissue atlas
There have been several valuable studies focused on sc transcriptomic analyses of human kidney tissue (6, 7, 9, 11) in the context of
different diseases. Although each of these studies have provided
substantial insight into disease processes, their mapping of reference
kidney tissue has often been limited to a single source of tissue and
focused on cell types relevant to the disease of interest. In contrast,
in this study, we have studied only human kidney specimens without
disease; we use multiple omics technologies, including regional and
sc/sn transcriptomics, proteomics, and spatial metabolomics in
conjunction with imaging assays to obtain an extensive, near-
comprehensive spatial map of the human kidney at the single-cell
resolution. Our experiments identify all known major cell types in
the kidney and recapitulate several known subtypes. In addition, we
can identify different types of endothelial cells, vascular smooth
muscle cells, fibroblasts, and different circulating immune cells.
Together, these different cell types and subtypes provide a detailed
picture of the cellular and molecular composition of the human kidney.
Here, we have extended our bioinformatics analyses beyond
ranked lists of genes (table S13) and associated pathways to identify
coherent networks of pathways that give rise to function. We have
developed our model in a systematic manner such that we identify
key functions for each cell type and subtypes. These physiological roles
identified through pathways and marker gene lists enable the development of a multiscale atlas that connects expression patterns to
whole-cell and tissue-level physiological functions. The proteomics
and metabolomics and the spatial imaging data from CODEX allows
for the mapping of sc/sn RNAseq–based cell type identification
to canonical cell type markers and appropriate spatial regions. This
exercise provides independent orthogonal validation of both the cell
type and the spatial localization within the nephron (Figs. 2A and 7).
Limitations and future refinements
Several limitations of our study should be noted. Not all cell types
are identified with the same certainty and depth, although our cell
types agree well with other published studies (6, 8, 11, 17). In addition, our sc/sn RNAseq assays contain a relatively low number of
cells compared to some of the contemporary studies. However, this
is compensated for by use of multiple omics and other technologies,
all of which provide convergent conclusions in the identification of
cell types.
As seen in our three-dimensional (3D) imaging assays, the
spatial distribution of different cell types within the kidney varies
11 of 20
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Fig. 8. Podocytes are the synthesis site for glomerular SM d18:1/16:0. (A) Matrix-
assisted laser desorption/ionization mass spectrometry imaging reveals that the
ion distribution of SM d18:1/16:0, [M + Na]+, correlates with the glomerular kidney
regions. (B) Podocytes express two genes involved in sphingomyelin synthesis
including the genes CERS6 that is identified by both sn and sc RNAseq datasets and
the LMD RNAseq dataset. CERS6 specifically generates C16 ceramides, the direct
precursor for SM d18:1/16:0. (C) CERS6 is also expressed in mesangial cells, although
only detected by the sn RNAseq dataset. Glomerular expression of the gene
SERINC2 is detected by the LMD RNAseq assay.

(53), while healthy podocytes form the glomerular slit diaphragm
(53). These observations indicate that we may be able to use decreased
levels of C16 SM and increased long-chain SM as a predictive biomarker for disease progression even before changes in glomerular
filtration rates.
The distribution of mRNAs for the various transporters mapped
in this study also agrees well with the known levels of reabsorption
activities identified in physiological experiments, suggesting that
the transporter mRNA levels along the nephron can provide an
indication of transcellular transport capacity for individual cell
subtypes. While our results are confirmatory of known physiology,
we note that only through our atlas, one will now have the framework to investigate the molecular mechanisms of renal dysfunction
in the context of individual cell subtypes and to generate hypotheses
that can be directly tested using physiological approaches.
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datasets that are obtained from 3 to 22 subjects (table S1). Kidney
tissue was procured from a spectrum of tissue resources including
from unaffected parts of tumor nephrectomy specimen (n = 38),
living donor preperfusion biopsies (n = 3), diseased donor nephrectomies (n = 5), and normal surveillance transplant (n = 5) and
native kidney biopsies (n = 4). Single-cell and sn transcriptomics
clusters were obtained from previous analyses (14, 15). Within each
assay, we generated lists of DEGs, differentially expressed proteins
(DEPs), and metabolites that describe those genes, proteins, or
metabolites that are up-regulated or enriched in a particular sc
cluster, sn cluster or kidney subsegment, if compared to all other
clusters or subsegments.
For pathway enrichment analysis and module identification,
cluster-specific DEGs were obtained from published analyses from
PREMIERE Tissue Interrogation Site (TIS) (Michigan, Princeton,
Broad) sc RNAseq (15) and UCSD/WU TIS sn RNAseq (14) datasets. We excluded the clusters PT cells 3 and principal cells 2 from
the sn RNAseq dataset since these clusters showed an inflammatory
stress response. Similarly, we excluded the cluster “Unk” from the sn
and the clusters “Pax8positivecells” and “LOH/DCT/IC” from the
sc RNAseq assays. LMD RNAseq and proteomics (OSUIU), NSC
proteomics (UCSF) and spatial metabolomics (UTHSA-PNNL-
EMBL) datasets were individually processed as described in the
Supplementary Materials. Only DEGs and DEPs that indicate genes
and proteins that are higher expressed in a particular cell subtype,
type, or segment were considered for all analyses.

METHODS

Dynamic enrichment analysis
Top DEGs and DEPs for each podocyte cluster/glomerulus, PT cell
cluster/tubulointerstitium, and principal cell cluster/collecting duct
subsegment were separately subjected to dynamic enrichment analysis using the MBCO (version 1.1) level-3 SCPs (22) that can be
found at github.com/SBCNY/Molecular-Biology-of-the-Cell and
www.mbc-ontology.org. The annotated interconnected hierarchy
of MBCO is enriched using a unique algorithm that infers weighted
relationships between functionally related SCPs. For all analyses, we
considered the top 25% weighted relationships. Dynamic enrichment analysis uses the top relationships to generate context-specific
higher-level processes by merging functionally related SCPs that
contain at least one DEG or DEP. The context-specific higher-level
SCPs contain all annotated genes of the original SCPs and are added
to the annotated ontology to generate a context-specific ontology.
The context specific ontology at this point contains single and
merged SCPs. This list is then used for enrichment analysis of the
DEPs or DEGs using Fisher’s exact test. All SCPs that are among the

Omics and imaging assays used within KPMP target different types
of molecular components with different resolution, sensitivity, and
precision. An important function of the KPMP Central Hub is to
integrate the different types of data using a set of analytical techniques. This process is summarized in Fig. 1. Throughout the paper,
we consistently use the same continuous color code to identify
different assays or cell types. The experimental assays that generate the
raw data and all their technical details including standard operating
procedures are detailed under “Data generation and initial analysis”
and publicly released with all their technical details and version-
controlled release dates on the KPMP protocols.io page (www.
protocols.io/groups/kpmp/publications).
Identification of DEGs, proteins, and metabolites
We analyzed data from four types of transcriptomic, two proteomic,
one imaging-based, and one metabolomic tissue interrogation assays.
The pilot data presented for each assay comprises 3 to 48 different
Hansen et al., Sci. Adv. 8, eabn4965 (2022)
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Ranking of DEGs and DEPs
In the case of the DEGs and DEPs that were used for dynamic
enrichment analysis, (22) module identification, (25) and post
hoc power analysis, sn and sc DEGs were first ranked by adjusted
P value and then by decreasing fold changes (i.e., fold changes
were used as a tiebreaker). Top ranked 300 entities with a maximum
adjusted P value of 0.05 were subjected to downstream analysis.
Similarly, DEGs and DEPs obtained for each kidney subsegment
based on LMD bulk RNAseq (19) or LMD and NSC proteomics
were ranked first by P value and decreasing fold changes, and the
top ranked 300 DEGs and DEPs with maximum nominal P value of
0.05 were subjected to pathway enrichment analysis or module
detection (see below).
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substantially; therefore, it is expected that the composition of sc/sn
RNAseq signatures also varies. When fewer cells are detected, typically, we also identify a lesser number of marker genes and SCPs.
Currently, we do not know whether the relative number of cells that
we detect in the sc/sn RNAseq assays reflect the proportions in situ.
Further sampling within the KPMP will likely resolve this issue. It is
also likely that further sampling will also enable mapping of SCPs in
every single-cell type with similar certainties. Nevertheless, for all
the major cell types of the kidney, post hoc power analyses indicate
that we have sufficient power to map the core cell-level functions
from SCPs generated from orthogonal assays. In addition, the
number and functional identity of major cell subtypes need to be
further studied. Currently, subtype identification is based on statistical reasoning used for the clustering algorithms. How many
subtypes there are for a given kidney cell and whether these subtypes
exist in all individuals require further studies using confirmatory
spatial imaging technologies. Studies in other tissues, such as brain
(54) and heart, have identified multiple subtypes of paraventricular
interneurons and ventricular myocytes. Hence, it is likely that kidney
cell types may also contain major subtypes. Despite these limitations, this study provides a detailed functional view of a kidney map
at the single-cell resolution, which can be used to understand major
aspects of kidney physiology, as demonstrated by the two examples
described above.
Information becomes knowledge only when it is deliberately and
systematically cataloged such that new cohesive insights can readily
be drawn, as shown above for sphingomyelin-related functions in
podocytes. Ontological classification could enable the generation of
new insights, especially when it involves multiscale relationships
between molecules, cell types and their subtypes and tissue level
physiological function. In addition to the integrated analytics
presented here, KPMP is also building a community-based Kidney
Tissue Atlas Ontology (55) that may aid such relationship building.
Together, the final knowledge environment and the kidney tissue
atlas constructed by KPMP, which is available at www.atlas.kpmp.
org, should be able to help molecularly characterize cellular types
and subtypes in the kidney, improve patient care by providing new
disease classifications, and may ultimately lead to new patient-
specific therapeutic approaches.
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Module detection
In parallel to enrichment analyses, we also performed another
network-based pathway enrichment technique, identifying modules of
cell type–specific marker genes within the kidney-specific functional
network using the HumanBase interface (hb.flatironinstitute.org).
For each cell type, module detection was performed using all cell
type–specific DEGs detected by sc and sn RNAseq (adjusted P value <
0.01) and segment-specific DEGs and DEPs detected by the other four
technologies (nominal P value < 0.01). Module detection is a network-based approach described by Krishnan et al. (25), and construction of the functional networks is described by Greene et al.
(24). In contrast to the prior knowledge-based MBCO networks, the
kidney-specific functional network is constructed using a data-driven
regularized Bayesian framework based on the information in thousands of datasets, which include coexpression, transcription factor
binding, protein-protein interactions, and other data types. Modules
are detected using a community clustering algorithm based on
connectivity between genes in the kidney-specific functional network,
Hansen et al., Sci. Adv. 8, eabn4965 (2022)
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and enrichment analysis is subsequently performed to identify functional enrichments in each module.
Enrichment analysis for metabolites
All glomerular and nonglomerular metabolites that were identified
for the three subjects were merged and subjected to pathway enrichment analysis using MetaboAnalyst (23) with the selections:
hypergeometric test, relative-betweenness centrality, Homo sapiens
(Kyoto Encyclopedia of Genes and Genomes), website version
3/22/2021. We analyzed which metabolites were part of the top
eight predicted metabolic pathways. We removed those pathways
among the top eight predictions that were predicted on the basis of
the metabolites that are shared substrates in multiple pathways and
consequently unspecific for the identified pathway [i.e., we ignored
the glomerular pathways “linoleic acid metabolism,” “alpha-linoleic
acid metabolism,” “glycosylphosphatidylinositol-anchor synthesis,” and “arachidonic acid metabolism” that were predicted on the
basis of the lipids “phosphatidylethanolamine” and “phosphatidylcholine” and the pathway “phenylalanine, tyrosine, and tryptophan
biosynthesis” that was predicted on the basis of the central precursor
“3-(4-hydroxyphenyl)pyruvate”]. We mapped the kept MetaboAnalyst pathways onto MBCO pathways whenever possible; if those
pathways did not have a corresponding MBCO pathway, then the
original pathway names were preserved. Since the nonglomerular
metabolites contained multiple carnitine derivates, we added the
MBCO pathways “carnitine shuttle” (based on l-acetylcarnitine,
malonyl-carnitine, l-palmitoylcarnitine, and l-carnitine) and “carnitine
biosynthesis and transport” (based on l-carnitine and 3-dehydroxycarnitine) to the pathways predicted from spatial metabolomics,
assigning the ranks 9 and 10, respectively.
Integration of single-cell/single-nucleus transcriptomics
In contrast to bulk mRNA sequencing, where the gene expression
measurements reflect an average across all captured cell types, sc
or sn mRNA sequencing allows the measurement and comparison
of comprehensive gene sets obtained from individual cells. This
approach enables mapping of cellular heterogeneity with high
throughput. In the first phase of the project, three KPMP tissue
interrogation sites (TISs) performed this approach to generate
sc/sn expression data from normal adult kidney tissue. In addition
to locally acquired kidney tissue samples, each TIS also used a set of
common KPMP pilot tumor nephrectomy tissue samples to generate the expression data. Sc transcriptomic data was produced by
PREMIERE (24 libraries from 22 subjects) (15) and UCSF (10 libraries
from 10 subjects), whereas the sn data were made by UCSD (47
libraries from 15 subjects) (14). Following is a brief description of
the integration of the data from the three sites.
Data from each site were first processed using the Seurat 3.0
R package (56). As a quality control step, nuclei/cells with less than
500 and more than 5000 features and more than 20% mitochondrial
genes were removed, yielding 17,529 and 13,130 cells along with
17,657 nuclei. The processing steps included normalization and
identification of highly variable genes. We then removed potential
doublets using DoubletFinder (57) from each dataset. Next, we used the
integration algorithm embedded in the Seurat R package to perform
combined analysis of sc/sn transcriptomic data. The integration
algorithm first identified a set of anchor genes in each processed
dataset. These anchor genes were then used to harmonize the datasets.
The downstream process included scaling, principal components
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first seven predictions are connected on the basis of the top inferred relationships using solid lines. All networks for a particular
cell type and the corresponding segment were merged, and each
SCP was color-coded according to the source assay(s) that initiated its
dynamic enrichment. SCPs predicted by multiple assays contain multiple slices that are color-coded accordingly. SCP size is determined by
the number of assays that identified a particular SCP. Multiple subtypes or a particular cell type (e.g., PT cells) are all color-coded by
the same assay specific color. If an SCP was predicted for more than
one subtype, it contains multiple slices colored with the assay
specific color. SCPs predicted by different assays for the same
cell type or corresponding segment were connected on the basis
of the top 25% inferred MBCO relationships using solid lines. Additional well-known functionally related SCPs were connected using
dashed lines.
We used the right-tailed Fisher’s exact test to calculate the likelihood of obtaining the observed or a higher overlap between a list of
DEGs/DEPs and a list of genes/proteins annotated to a particular
SCP. To calculate this likelihood, we consider which genes or
proteins have a chance to be identified as differentially expressed.
Only genes/proteins that are detected by a particular assay and are
statistically analyzed for differential expression can be identified as
DEGs/DEPs. Consequently, only these genes/proteins are considered
as the experimental background set for the Fisher’s exact test. Similarly, the ontology background set only contains genes that have a
chance to be assigned to a given SCP. In the case of the sc (15) and
sn (14) RNAseq datasets, all genes that are part of the UMI (unique
molecular identifier) read count matrices comprise the experimental background genes. In the case of the LMD bulk RNAseq and
the LMD and NSC proteomics datasets, the experimental background genes/proteins were all genes/proteins that were statistically
analyzed for differential expression (tables S2 to S4, respectively).
MBCO contains an SCP that is labeled “Background genes” and
contains all genes that were identified during its population via text
mining. The intersection of the experimental and ontological background genes/proteins is called background genes/proteins and is
different for every assay and ontology combination. For additional
statistical accuracy, we removed all genes and proteins that were
not part of the background genes/proteins from the lists of DEGs,
DEPs, and SCP genes before each enrichment analysis.
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analysis, batch integration using harmony, dimensionality reduction using uniform manifold approximation and projection, and
unsupervised clustering. The clustering was performed at low resolutions (clustering granularity of 0.5). Enriched genes for each cluster
compared to all other clusters were identified using the Wilcoxon
rank-sum test.

Proteomic-transcriptomic coexpression analysis
LMD and NSC proteomic datasets identified protein expression in
two kidney subsegments: glomeruli and tubulointerstitium for LMD
and glomeruli and PT for NSC. Here, we did not combine sequencing
and proteomic results of multiple subjects to generate DEGs and
DEPs but compared the results obtained for each individual person.
Because only one dataset per segment was generated from each
individual person by the LMD and NSC technologies, we could not
calculate P values in this analysis. Furthermore, both proteomic
technologies only generated results for two subsegments, i.e., the
glomerular and PT segments for NSC proteomics and the glomerular
and tubulointerstitial subsegments for the LMD proteomics.
Consequently, we collectively calculated the fold changes between
podocyte/glomeruli and PT/tubulointerstitial cells or subsegments
for each individual subject.
For the sc and sn transcriptomic datasets, we identified technology-, subject- and cell type–specific gene expression, using the
“Average Expression” functionality embedded in the Seurat R
package (RNA assay and counts slot) on the integrated single cell
and nucleus RNAseq data analysis described above (fig. S2). For
each technology, we characterized all genes/proteins that were
identified in at least one cell type or subsegment of at least one
subject and defined these genes/proteins as a technology-specific
background set. The intersection of all background sets was defined
as the set of common genes/proteins. Subject-specific podocyte or
glomerular gene and protein expression was calculated by dividing
gene and protein expression in podocytes, or glomeruli, by gene and
protein expression in PT cells or PT/tubulointerstitial subsegments,
after adding 1 to prevent division by 0. Ratios were inverted to
describe PT/tubulointerstitial-specific gene expression. Log10 absolute expression values and log2 ratios of all genes/proteins or all
Hansen et al., Sci. Adv. 8, eabn4965 (2022)
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Comparison of cell type–specific imaging and transcriptomic
expression data
Clustering of the CODEX data was performed using 31 features
(size and 30 protein markers: AQP1,CD34,THP,CK7,CD104,
CD7,podoplanin,CD16, CD38, CD279, CD4, CD8, CD278, CD3,
COLIV, AQP2, CD11c, CD21, CD19, CD138, CD31, CD45, Ki67,
SYNPO, CD90, HLA-DR, CD68, CD9, pan-CK, and calbindin)
using the most recent version of the VorTeX software (26 April 2018
release). Before clustering, cells were filtered to only those with QC
parameter of 1, and each feature was scaled to have mean 0 and SD
of 1 across all remaining cells. X-shift clustering was performed
using parameters as specified by Black et al. (58). The clustering with
K (number of neighbors for the density estimate) of 60 (31 clusters)
was selected using the elbow point method. The normalized intensities of each marker were averaged within each cluster to generate
per-cluster profiles and three clusters corresponding to background
or noisy signal were removed. To map between the CODEX clusters
and the integrated sc/sn dataset, all features were used except for
size, pan-CK, and COLIV. Integrated sc and sn data were normalized
and scaled, and the average expression value of each marker was determined for each sc cluster. Genes in the sc data were subsetted to
genes matching CODEX features (AQP1, CD34, UMOD, KRT7,
ITGB4, CD7, PDPN, FCGR3A, CD38, PDCD1, CD4, CD8A, ICOS,
CD3D, AQP2, ITGAX, CR2, CD19, SDC1, PECAM1, PTPRC,
MKI67, SYNPO, THY1, HLA-DRA, CD68, CD9, and CALB1). The
Pearson correlation between each CODEX cluster and each single-cell
cluster was computed, and each CODEX cluster was mapped to the
single-cell cluster with the maximum Pearson correlation.
Post hoc power analysis
The sc and sn RNAseq datasets were obtained from 22 and 15 subjects, respectively, whose samples were sequenced in 24 and 47
libraries (table S1). We used these datasets to assess the reproducibility and reliability of both assays in a post hoc power analysis.
This analysis compares results by the complete datasets with the
results by down-sampled datasets where libraries are randomly and
progressively removed from the complete data.
Both complete datasets were separately subjected to a standardized
Seurat pipeline for the identification of sc or sn clusters and
DEGs (fig. S5A). Nuclei and cells with less than 400 or 500 features,
respectively, and more than 5000 features as well as more than 50%
mitochondrial genes were removed. “SCTransform” was used for
data normalization and scaling (based on top 2000 features),
followed by principal components analysis. The first 30 principal
components were used for dimensionality reduction before identifying
cell neighborhoods using the Seurat functionality “FindNeighbors.”
Our analysis pipeline now searched for an optimal resolution
that identified as many predefined cell types as possible. The predefined cell types included all major kidney cell types for both sc
and sn RNAseq datasets, while we excluded the immune cell types
14 of 20
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Integration of single-cell, single-nucleus, and laser capture
microdissection bulk transcriptomics
To integrate sc sequencing, sn sequencing, and LMD bulk transcriptomic datasets, we first determined the overlap between genes
identified both in the LMD dataset and in the corresponding
single-cell transcriptomic dataset. From this set of shared genes, we
restricted further analyses to a subset of genes showing variable expression in the single-cell dataset. We then computed the Pearson
correlation between each individual cell in a scaled single cell/single
nucleus dataset and the LMD transcriptomic dataset. For this correlation, we used the logarithmized mean fold change that was obtained by dividing the average expression of each gene within a
subsegment by the average expression of the same gene within all
other subsegments. Using this approach, we can assign each cell to
the appropriate LMD segment that shows the highest correlation
value. To evaluate the overall segment assignments for individual
cell clusters, we examine the normalized distribution of cells assigned
to each LMD segment within a given single-cell cluster and present
this as a normalized heatmap that represents overlap between
different transcriptomic assays.

common genes/proteins were subjected to pairwise correlation,
followed by hierarchical clustering. Log2 ratios were averaged over
each subject within each technology and pairwise Pearson correlation coefficients were determined between the different technologies
using the set of common genes. Mean log2 ratios were averaged
across the four RNAseq platforms and the two proteomic platforms,
followed by determination of the Pearson correlation coefficient
using the set of common genes.
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a different subsegment to be negative. We calculated the Pearson
correlation between the DEGs of each cell type in the downsampled
datasets and the reference datasets based on log2 fold changes.
Pathway enrichment analysis normally involves identification of
the most significant pathways irrespective of their P values. To
document the reliability of the SCPs that were among the top seven
predictions in the complete dataset, we identified the ranks of these
SCPs in each downsampled dataset as well. Ranks were averaged for
each SCP and number of analyzed libraries.
Documentation of cellular metabolism
We generated a small ontology that contains the major metabolic
pathways involved in energy generation and sphingomyelin synthesis.
We defined parent-child relationships, where child pathways described subfunctions of their parent pathways (fig. S17A). Pathways
were populated with genes curated from the literature, parent
pathways also populated with the genes of their child pathways. The
ontology is publicly available at github.com/SBCNY/Molecular-
Biology-of-the-Cell and mbc-ontology.org. Before enrichment analysis,
we added all genes of the “Gene_ontology_biological_process_2018”
library that we downloaded from the enrichR website (59) as background genes of the ontology.
We subjected the top 500 significant marker genes and proteins
(sc/sn RNAseq: adjusted P value 0.05, LMD RNAseq, LMD/NSC
proteomics: nominal P value 0.05) to enrichment analysis using this
ontology and Fisher’s exact test. Investigation of the predicted pathways that are specific for a particular reaction allowed to decide in
which reaction(s) those enzymes participate that are shared by
multiple pathways. Child pathways that specifically describe the
function of their parent pathways are visualized in the same color in
fig. S17A. If only pathways that contained the shared reactions of
multiple parent pathways were predicted, we assumed that they
participated in the default parent pathways “glycolysis,” “ketone body
catabolism” or “aerobic glycolysis.”
Because the sn RNAseq data were derived from cortical, medullary,
and mixed samples (fig. S4B), we distinguished between medullary
(DTL, ATL1-3, TAL-1, PC-3, and IC-A2, for abbreviations see
Fig. 2A) and cortical cell types (all other cell types of the renal tubule
of the nephron). All other datasets were assigned as cortical. Enrichment result negative log10 P values were first averaged across the
different cell subtypes of the same cell type and then across the
different transcriptomic datasets. In case of the sc and sn RNAseq
assays, we considered the number of cells assigned to each subtype
of a particular cell type. The averaged negative log10 P values is
representative of the cell counts of each cluster.
Because marker genes characterize those genes that are higher
expressed in a particular cell type, subtype, or subsegment if
compared to all other cell types or subsegments, missing identification of a particular pathway does not mean that there is no pathway
activity at all. For example, we did not identify any podocyte marker
genes involved in any of the analyzed energy generation pathways,
although podocytes can generate energy by anaerobic glycolysis
(60). Here, our analysis simply documents that the levels for those
genes are lower in podocytes than in most of the other kidney cells.
Comparison of experimental reabsorption and gene
expression profiles
Experimentally determined reabsorption capacity profiles that
describe what percentage of a filtered sodium or glucose is reabsorbed
15 of 20
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in case of the single nucleus datasets. Our pipeline identified clusters
using the Seurat functionality “FindClusters” and an initial resolution of 0.5, followed by annotation of cell types to each cluster.
Briefly, our pipeline calculates cluster-specific marker genes using
the Seurat functionality “FindAllMarkers” and an adjusted P value
cutoff of 0.05. If more than 300 marker genes were identified, we
only used the top 300 most significant genes for cell type annotation.
Marker genes of each cluster were compared with literature-curated
cell type–specific essential genes (table S10) using Fisher’s exact
test. For each cluster we generated a list of cell type assignments
that can be ranked by significance P values. If the quotient of the
first and the second most significant P values was smaller than 0.05,
our pipeline assigned the cell type associated with the first P value to
that particular cluster. If not, it investigated if the quotient between
the second and the third most significant P values is smaller than
0.05. In this case, it assigned both the first and second cell type to
that particular cluster. This way our algorithm acknowledges that
closely related cell types cannot always be distinguished from each
other based on sc/sn RNAseq datasets (e.g., PT and descending
limb cells). If the quotient between the second and third P values is
higher than 0.05, our pipeline left that cluster unassigned. Our
pipeline now analyzed whether all predefined cell types were identified (ignoring double cell type assignments). If not, it increased
the resolution by 0.1 and repeated all steps leading to cluster identification and cell type annotation, until all predefined cell types were
identified or a maximum resolution of 2.0 was achieved. The final
selected resolution was that resolution that lead to the identification
of the highest number of predefined cell types, under the requirement that all cell types that were identified at lower resolutions
needed to be identified at this resolution as well. If this was not the
case, we ignored the resolution completely. If multiple resolutions
identified the same number of cell types, we selected that resolution
that was associated with the lowest number of cells belonging to clusters with no cell type annotation. If there were still multiple candidate
resolutions, we selected the lowest one. Clusters annotated to the
same cell types were merged and cell type–specific marker genes
were calculated (adjusted P value = 0.05).
Nuclei and cells that were assigned to a particular cell type and
map or did not map to the corresponding LMD tissue subsegment
were counted, using the subsegmental correlation analysis described
above. Cell type–specific marker genes were subjected to dynamic
enrichment analysis using MBCO. If more than 300 marker genes
were identified, we only subjected the top 300 genes. All SCPs
among the top seven predictions were further investigated.
We progressively and randomly removed libraries from the
complete (reference) datasets to generate 100 non-overlapping
downsampled datasets for each number of remaining libraries.
Down-sampled data were subjected to the same analysis pipeline
and results were compared with the reference results. We calculated
the percentage of downsampled datasets for each number of
remaining libraries that identified a particular cell type. If a particular
cell type was identified in a down-sampled dataset, we counted how
many of its nuclei/cells were assigned to the same or to a different
cell type in the reference analysis. To visualize both counting results
in the same plot, we defined those cell counts that mapped to a
different cell type to be negative, so these counts are plotted below
the abscissa. Similarly, we counted how many nuclei/cells of a
particular cell type mapped and did not map to a particular tissue
subsegment. Here, we also defined those cell counts that mapped to
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in a particular nephron segment were curated from standard medical
and physiological text books (30, 31, 33, 61), followed by averaging
of the curated numbers for each ion or molecule. As these are
widely used medical school textbooks, we assumed that the information is correct and did not further track down the values given in
these books to the primary papers from which these values were
obtained. In addition, we assumed conversation of physiological
processes across mammalian species, and we did not ascertain
whether all values were derived from the same species or more than
one species.
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Calculation of predicted reabsorption capacities
Besides our own sc and sn RNAseq dataset (14, 15), we used two different sn RNA seq datasets that were generated from undiseased tissue
as well (16, 17). All datasets document how many mRNA molecules are transcribed from each gene in each individual cell. These
numbers are described as UMI counts (62), but in this study, we use
the term mRNA counts or levels to indicate that it is a quantitative
measure of mRNA levels of a certain species. The cells and nuclei in the
sc and sn RNAseq datasets were previously grouped into clusters
using standard software packages, followed by identification of
cluster-specific marker genes and cell type and subtype annotation
(14, 15, 17). We analyzed the raw UMI matrix (GSE114156) (16) using
the Seurat package (as outlined in fig. S5A) and annotated kidney cell
types based on cell type–specific gene expression (table S10).
We assumed that that mRNA molecule counts (i.e., UMI counts)
of each transporter or channel in each cell reflect the capacity of that
particular cell for transmembrane movement of that particular ion
or molecule. The following explanation of how we predicted movement capacities from those mRNA levels is summarized in fig.
S19A. We initially processed all four datasets, i.e., one sc RNAseq
and three sn RNAseq datasets, independently. For each dataset and
SCP of our transmembrane movement ontology we summed up all
mRNA molecules that are expressed in all cells of a particular cell
type or nephron segment and map to genes involved in that SCP. It
should be noted that we documented total and not mean capacities,
because we did not divide the mRNA count sums by the number of
cells in each particular cell type or segment. If a particular cell type
or nephron segment contains more cells, it is assumed to contribute
more to the reabsorption of a particular ion or molecule, if the
appropriate transporter is present. Measured physiological reabsorption profiles describe net lumen-to-blood transport values in
each segment. To account for the different transport directions
predicted from SCPs that are involved in lumen-to-blood and
blood-to-lumen transport, we defined all mRNA levels mapping to
blood-to-lumen transport SCPs as negative. This allowed the calculation of net lumen-to-blood transport capacities by adding up all
mRNA counts involved in lumen-to-blood transport and all (negative) mRNA counts involved in blood-to-lumen transport of each
ion or molecule. Because the physiological profiles document how
much percent of a particular ion or molecule is reabsorbed in a
particular nephron segment, we expressed all SCP capacities in percent
of the net lumen-to-blood transport capacities of the corresponding
ions or molecules. Consequently, the sum of all predicted transport
capacities along the nephron is 100% for both sodium and glucose
(mRNA levels assigned to blood-to-lumen transport are still defined
as negative), allowing the direct comparison of mRNA levels and
reabsorption profiles. Any SCPs that mediate the transport of
16 of 20
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Generation of a transmembrane transport ontology
Because human single cell and single nucleus RNAseq datasets
(14–17) contain gene expression profiles in all major nephron cell
types, we reasoned we could compare segment specific gene expression levels of the transporter or channel of interest with these
physiologically measured reabsorption profiles. Using gene ontology
MBCO (22), Wikipedia articles, and selected reviews as sources
(36, 40), we generated a comprehensive ontology of transmembrane
transporter at the plasma membrane (fig. S19A). Within gene
ontology, we focused on all biological processes and molecular
functions that were children of “sodium ion transport,” “sodium ion
transmembrane transporter activity” as well as “glucose transport,”
“glucose transmembrane transporter activity,” as defined by the
“is_a” and “part_of” relationships. From MBCO, we added all genes
assigned to the SCP “sodium transmembrane transport.” The initial
list of transporter candidates was manually investigated to validate
their transporter activity. True positives were assigned to de novo
SCPs that describe the movement mechanism (i.e., transport via
symporter or antiporter), the movement direction (i.e., lumen-toblood or blood-to-lumen) and all ions or molecules that are transported by that mechanism. In case of antiporters, we specified
which ions or molecules move in opposing directions by separating
them with the term “vs.” If the protein translated from a particular
gene had a unique name that is commonly used and is different
from the official National Center for Biotechnology Information
(NCBI) gene symbol, we assigned the gene to that particular protein
name (e.g., SLC12A1 and SCL12A3 were assigned to NKCC2 and
NCC, respectively). Here, we did not describe the activity mediated
by that protein (e.g., “sodium potassium chloride transport by the
symporter NKCC2”), because this would create unnecessarily long
names in our figure legends. Nevertheless, in all analyses, these proteins were processed as if they were SCPs. Consequently, whenever
we use the term SCP in the manuscript, we refer to these proteins as
well. Each SCP-gene association was supported by at least one
reference that could be the NCBI gene summary, UniProt gene summary or a PubMed ID for a supporting article (table S12). To allow
systematic analysis and grouping of transmembrane movements,
we integrated all SCPs into a SCP hierarchy of parent and children
SCPs (fig. S19B) using a strategy we have described for the MBCO
ontology (22). This hierarchy converges children on parent SCPs
that describe more generalized shared transport mechanisms. For
example, the SCP “sodium potassium chloride symporter” (that is
the parent of the SCP “NKCC”) is the child of the two parent SCPs
“sodium chloride symporter” and “sodium potassium symporter.”
We left out the SCP “potassium chloride symporter,” because here,
we focused on sodium and glucose transmembrane transport. These
SCPs are then connected to the higher-level SCP “sodium lumento-blood transport by symporter.” For both sodium and glucose all

SCPs finally converge on either one of two different overall parent
SCPs describing transcellular lumen-toward-blood transport and
transcellular blood-toward-lumen transport. Discussed example
of SCP relationships and two additional examples are shown in fig.
S19B. Figure S19C shows the hierarchical organization of all SCPs
involved in sodium lumen-to-blood and blood-to-lumen transport.
All parent SCPs were populated with the genes of all of their
children SCPs. Last, we kept only those genes in the ontology that
localize to the plasma membrane based on the jensenlab human
compartment ontology with a minimum confidence score of 4
(out of maximal 5) (www.compartments.jensenlab.org).
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multiple ions or molecules were normalized independently for each
ion and molecule to calculate the relative contribution of that SCP
to the total reabsorption capacity of each ion or molecule. Final
percentages of the same SCPs predicted by the three sn RNAseq
datasets or all four datasets were averaged.
Identification of cell type markers
Marker genes and proteins of each cell subtype or segment were
ranked as described above. If multiple cell subtypes were identified
on the basis of the single cell or single nucleus RNAseq datasets, we
calculated the average rank for that cell type. Original or averaged
ranks were averaged again over the different assays for each cell type
and selected segment, followed by reranking. The top five reranked
genes/proteins were selected as cell type markers in table S12. To
identify combinations of markers that best define each cell type, we
also used a machine learning approach (63) to find marker combinations that optimally separate each cell type from all other cell types
for sc, sn, and integrated sc/sn RNA-seq datasets.

Data generation and initial analysis
Seven different RNAseq, proteomics, metabolomics, and imaging
datasets were generated and analyzed by five different TISs. The
PREMIERE TIS (composed of Michigan, Princeton, Broad) generated sc RNAseq data, the USCD/WashU TIS generated sn data, the
UCSF TIS generated sc RNAseq, NSC proteomics and Codex
imaging data, the IU/OSU TIS generated LMD RNAseq and LMD
proteomics data, and the UTHSA-PNNL-EMBL TIS generated spatial metabolomics data.
Sn RNAseq (UCSD/WashU) and single-cell RNAseq (PREMIERE)
UMI count matrixes and list of DEGs were downloaded from
published analyses for the PREMIERE TIS (composed of Michigan,
Princeton, Broad) single-cell RNAseq (15) and UCSD/WashU TIS
Single-nucleus RNAseq (14) datasets. We excluded the PT cells-3
and principal cells-2 clusters from the single-nucleus RNAseq dataset,
because these clusters showed an inflammatory or a stress response.
Subsegmental LMD transcriptomics (IU/OSU)
A comprehensive LMD protocol is published on protocols.io (www.
protocols.io/view/laser-microdissection-8rkhv4w). Briefly, 12-m
frozen sections are obtained from an optimal cutting temperature
(OCT) preserved tissue block and adhered to LMD membrane
slides (Leica, Buffalo Grove, IL). The tissue undergoes a rapid staining protocol involving acetone fixation, washes with ribonuclease
(RNAse)–free phosphate-buffered saline, and antibody incubation
in 10% bovine serum albumin. The slides undergo dissection with a
Leica LMD6500 system with pulsed ultraviolet laser. After collecting
a minimum tissue area of 500,000 m2 in an RNAse-free microcentrifuge tube, the RNA is isolated using the PicoPure RNA Isolation
Kit according to the manufacturer’s instructions (Applied Biosystems,
catalog no. KIT0204). The RNA quality is assessed by Bioanalyzer;
ribosomal RNA is depleted, and cDNA libraries are prepared using
the SMARTer Universal Low-Input RNA Kit (Takara, no. 634938).
Sequencing was conducted on an Illumina HiSeq 4000. Mapping
was performed using STAR (v2.5.2b), and read counts were quantified with featureCounts (subread v.1.5.0). Total read counts mapping
to each gene were generated with edgeR, normalized, and converted
to expression ratios.
Hansen et al., Sci. Adv. 8, eabn4965 (2022)
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Generation of nephron schema
We used BioRender.com to create the nephron schema in Fig. 7.

Segment-specific gene expression was compared to the gene
expression in all other subsegments using an unpaired t test with
equal variance. Subsegment-specific gene expression ratios were
calculated similarly.
Subsegmental LMD proteomics (IU/OSU)
A comprehensive LMD proteomics protocol is published on
protocols.io (www.protocols.io/view/laser-microdissection-forregional-transcriptomics-8rkhv4w?version_warning=no). Our LMD
proteomic methods have also been previously published in detail
(64, 65). Briefly, 10-m frozen sections are obtained from an
OCT-preserved tissue block and adhered to polyethylene naphthalate
membrane slides for LMD. Frozen sections are fixed in 70% ethanol,
incubated in H2O to remove OCT, briefly stained with hematoxylin,
and dehydrated in ethanol. LMD is performed and glomeruli and tubulointerstitial samples are collected separately in 0.5% RapiGest/50 mm
NH3HCO3 solution. The collected samples are then boiled for
20 min for protein retrieval and digested overnight with trypsin.
Peptides are dried, resuspended in acetonitrile/formic acid, and
analyzed using liquid chromatography tandem–mass spectrometry
analysis using an Easy-nLC 1000 HPLC coupled to an Orbitrap
Fusion mass spectrometer (Thermo Scientific, Waltham, MA). Data
are searched using Proteome Discoverer 2.1 (Thermo Scientific)
and searched against a human UniProt database (version 05/26/18).
Data are analyzed following global normalization of spectral counts.
Glomerular gene expression was compared to the tubulointerstitial
gene expression using an unpaired t test with equal variance.
Glomerular to tubular-specific gene expression ratios were calculated
similarly.
3D immunofluorescence imaging and tissue
cytometry (IU/OSU)
The entire 3D fluorescence imaging and tissue cytometry protocol
is published on protocols.io (dx.doi.org/10.17504/protocols.
io.9avh2e6). Briefly, frozen cores are sectioned at 50 m using a cryostat
and fixed using 4% paraformaldehyde. A panel of up to eight antibodies was incubated to identify renal and immune cell types. Images
were acquired in up to eight channels using a Leica SP8 confocal
microscope. Volume stacks spanning the whole thickness of the tissue
were taken using a 20× numerical aperture (NA) 0.75 or 40× NA
1.3 objectives with 0.5- to 1.0-m spacing. Large-scale confocal
imaging of overlapping volumes was performed with an automated
stage and stitched using Leica LASX software (Germany). A 3D
image rendering was done using Voxx v2.09d. The 3D tissue cytometry
was performed on image volumes using VTEA, which was developed
as a plugin for ImageJ/Fiji as previously described (66).
CODEX imaging (UCSF)
The CODEX technology comprises of immunofluorescence staining
with antibodies conjugated to unique oligonucleotide sequence
targeting markers of interest probed with complementary oligonucleotide reporters tagged to fluorophores (67). CODEX fluidics
instrument is used for iterative cycles of imaging, dye, and reporter
removal allowing high plexity. 4′,6-Diamidino-2-phenylindole for
nuclear signal along with complementary oligonucleotide probes
tagged to Alexa Fluor 488, Atto 550, and Cy5 fluorophores are
revealed in each cycle. CODEX Software Suite allows raw image
processing for subtraction of background noise, deconvolution to
eliminate out-of-focus light, collapsing z-stacks into single best
focus, shading correction, and cycle alignment in addition to
image segmentation based on watershed algorithm. Flow cytometry
standard expression data and raw images as TIFF files are generated

SCIENCE ADVANCES | RESEARCH ARTICLE

SUPPLEMENTARY MATERIALS

Supplementary material for this article is available at https://science.org/doi/10.1126/
sciadv.abn4965
View/request a protocol for this paper from Bio-protocol.
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and can be visualized in external software for gating, clustering, and
phenotyping.
Transplant normal biopsy was stained with 29-plex panel of
CODEX antibodies, followed by immunofluorescent staining of
calbindin and imaged at 20× resolution on a Keyence BZ-X710
microscope. Raw data were transferred and processed with CODEX
Software Suite comprising CODEX Instrument Manager and
processor. Processed data were visualized in the CODEX Multiple
Analysis Viewer (MAV), an ImageJ plugin to eliminate artifacts,
assess cell segmentation, gating, annotation, and generation of
subpopulation for downstream analyses. Clustered population were
visualized in MAV by overlaying with corresponding markers and
annotated population to assess cell type enrichment.
Spatial metabolomics (UTHSA-PNNL-EMBL)
Ten-micrometer-thick renal cortical tissues were sectioned using
a cryostat (Leica Microsystems), thaw-mounted on indium tin
oxide–coated slides (Bruker Daltonics), and prepared for matrix-
assisted laser deposition/ionization mass spectrometry (MALDI-MSI)
by spraying with 2,5-dihydroxybenzoic acid (40 mg/ml in 50%
MeOH:H2O) using the TM-Sprayer automated spraying robot (HTX
Technology). The following spraying parameters were used: 80°C
nozzle temperature, a flow rate of 0.05 ml/min, 10 passes, a N2 pressure of 10 psi, a track spacing of 3 mm, and a 40-mm distance
between the nozzle, and sample was maintained. MALDI-MSI was
performed using a MALDI-Fourier-transform ion cyclotron resonance (FTICR) imaging mass spectrometer (Bruker Daltonics) set
at a 120,000 resolving power at mass/charge ratio (m/z) 400 or a
MALDI-Orbitrap mass spectrometer (Thermo Scientific) set at the
120,000 resolving power at m/z 200. The data were inspected following the quality control guidelines as developed within KPMP
and converted into the imzML centroided format using the SCiLS
software (Bruker Daltonics) or ImageInsight software (Spectroglyph
LLC), followed by the submission to METASPACE and annotation
against the SwissLipids and Human Metabolome Database (HMDB)
molecular databases with the false discovery rate of 20%, as described in (68).
We have developed an approach to find glomeruli markers in
MALDI-MSI data by using METASPACE and colocalization analysis. First, we have selected a template marker that was localized
within the glomerular regions, as confirmed by the histology.
This ion was annotated by METASPACE as ceramide phosphate
CerP(d34:1) (68). Then, we performed a spatial colocalization analysis
by calculating for all other detected metabolites and lipids their
spatial correlation with CerP(d34:1) using the cosine score. The
molecules with the correlation above 0.2 were considered and manually curated to show the colocalization with the glomeruli regions
by overlaying every ion image with the histological image. The
resulting 30 markers were uploaded to the KPMP DataLake and
were used for the multiomics integration analysis.
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